{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:35:23Z","timestamp":1771054523326,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1698-y","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T23:20:46Z","timestamp":1485300046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Artemether-lumefantrine and liver enzyme abnormalities in non-severe Plasmodium falciparum malaria in returned travellers: a retrospective comparative study with quinine-doxycycline in a Portuguese centre"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-3356","authenticated-orcid":false,"given":"Andr\u00e9","family":"Silva-Pinto","sequence":"first","affiliation":[]},{"given":"Rog\u00e9rio","family":"Ruas","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duro","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Silva","sequence":"additional","affiliation":[]},{"given":"C\u00e2ndida","family":"Abreu","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"1698_CR1","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.","edition":"3"},{"key":"1698_CR2","unstructured":"WHO. Antimalarial drug combination therapy. Report of a WHO Technical Consultation. World Health Organization, 2001."},{"key":"1698_CR3","doi-asserted-by":"crossref","unstructured":"McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000;(2):CD000527.","DOI":"10.1002\/14651858.CD000527"},{"key":"1698_CR4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"J Achan","year":"2011","unstructured":"Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.","journal-title":"Malar J."},{"key":"1698_CR5","first-page":"107","volume":"2","author":"IO Omotuyi","year":"2008","unstructured":"Omotuyi IO, Nwangwu SC, Okugbo OT, Okoye OT, Ojieh GC, Wogu DM. Hepatotoxic and hemolytic effects of acute exposure of rats to artesunate overdose. Afr J Biochem Res. 2008;2:107\u201310.","journal-title":"Afr J Biochem Res"},{"key":"1698_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/tox.21907","volume":"30","author":"SE Owumi","year":"2015","unstructured":"Owumi SE, Gbadegesin MA, Odunola OA, Adegoke AM, Uwaifo AO. Toxicity associated with repeated administration of artemether\u2013lumefantrine in rats. Environ Toxicol. 2015;30:301\u20137.","journal-title":"Environ Toxicol"},{"key":"1698_CR7","doi-asserted-by":"crossref","first-page":"e94034","DOI":"10.1371\/journal.pone.0094034","volume":"9","author":"JY Yin","year":"2014","unstructured":"Yin JY, Wang HM, Wang QJ, Dong YS, Han G, Guan YB, et al. Subchronic toxicological study of two artemisinin derivatives in dogs. PLoS One. 2014;9:e94034.","journal-title":"PLoS One"},{"key":"1698_CR8","first-page":"50","volume":"58","author":"IR Ribeiro","year":"1998","unstructured":"Ribeiro IR, Olliaro P. Safety of artemisinin and its derivatives: a review of published and unpublished clinical trials. Med Trop (Mars). 1998;58:50\u20133.","journal-title":"Med Trop (Mars)."},{"key":"1698_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1345\/aph.18172","volume":"33","author":"DK Farver","year":"1999","unstructured":"Farver DK, Lavin MN. Quinine-induced hepatotoxicity. Ann Pharmacother. 1999;33:32\u20134.","journal-title":"Ann Pharmacother"},{"key":"1698_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","volume":"32","author":"PC Heaton","year":"2007","unstructured":"Heaton PC, Fenwick SR, Brewer DE. Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study. J Clin Pharm Ther. 2007;32:483\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"1698_CR11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archinte.1990.00390170136029","volume":"150","author":"RC Punukollu","year":"1990","unstructured":"Punukollu RC, Kumar S, Mullen KD. Quinine hepatotoxicity. An underrecognized or rare phenomenon? Arch Intern Med. 1990;150:1112\u20133.","journal-title":"Arch Intern Med"},{"key":"1698_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0035-9203(00)90126-3","volume":"94","author":"R Bakshi","year":"2000","unstructured":"Bakshi R, Hermeling-Fritz I, Gathmann I, Alteri E. An integrated assessment of the clinical safety of artemether\u2013lumefantrine: a new oral fixed-dose combination antimalarial drug. Trans R Soc Trop Med Hyg. 2000;94:419\u201324.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1698_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.2011.11-0069","volume":"85","author":"M Makanga","year":"2011","unstructured":"Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, et al. Efficacy and safety of artemether\u2013lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg. 2011;85:793\u2013804.","journal-title":"Am J Trop Med Hyg"},{"key":"1698_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/17512433.2014.907523","volume":"7","author":"B Angus","year":"2014","unstructured":"Angus B. Novel anti-malarial combinations and their toxicity. Expert Rev Clin Pharmacol. 2014;7:299\u2013316.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"1698_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","volume":"40","author":"T Efferth","year":"2010","unstructured":"Efferth T, Kaina B. Toxicity of the antimalarial artemisinin and its dervatives. Crit Rev Toxicol. 2010;40:405\u201321.","journal-title":"Crit Rev Toxicol"},{"key":"1698_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.toxlet.2003.12.009","volume":"147","author":"T Gordi","year":"2004","unstructured":"Gordi T, Lepist EI. Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol Lett. 2004;147:99\u2013107.","journal-title":"Toxicol Lett"},{"key":"1698_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1742-7843.2008.00211.x","volume":"102","author":"OA Adaramoye","year":"2008","unstructured":"Adaramoye OA, Osaimoje DO, Akinsanya AM, Nneji CM, Fafunso MA, Ademowo OG. Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether\u2013lumefantrine and halofantrine in rats. Basic Clin Pharmacol Toxicol. 2008;102:412\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1698_CR18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","volume":"7","author":"L Cui","year":"2009","unstructured":"Cui L, Su XZ. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther. 2009;7:999\u20131013.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"1698_CR19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/QCO.0b013e32834cabdb","volume":"24","author":"F Kurth","year":"2011","unstructured":"Kurth F, Belard S, Basra A, Ramharter M. Pyronaridine-artesunate combination therapy for the treatment of malaria. Curr Opin Infect Dis. 2011;24:564\u20139.","journal-title":"Curr Opin Infect Dis."},{"key":"1698_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(03)15162-8","volume":"363","author":"M Adjuik","year":"2004","unstructured":"Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9\u201317.","journal-title":"Lancet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:59:43Z","timestamp":1498366783000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1698-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1698"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1698-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]},"article-number":"43"}}